RecruitingNot applicableNCT06714097
Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)
Studying Hereditary cerebral amyloid angiopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- Intervention
- AI(device)
- Enrollment
- 20 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2027
Study locations (1)
- Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Michigan, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06714097 on ClinicalTrials.govOther trials for Hereditary cerebral amyloid angiopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT05709314A Study of AMDX-2011P in Participants With CAAAmydis Inc.
- RECRUITINGPHASE2NCT06393712A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid AngiopathyAlnylam Pharmaceuticals
- RECRUITINGNCT04204642SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA)Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- ACTIVE NOT RECRUITINGNCT06128824High Frequency Imaging in Cerebral Amyloid AngiopathyMartin Dichgans